Joyce M. Richey, PhD

Professor of Clinical Physiology & Neuroscience and Medical Education

Associate Dean for Student Engagement and Cultural Affairs

Image of Joyce M. Richey, PhD
Is this your profile? Click to edit

Overview

Dr. Richey is currently a faculty member in the department of Physiology and Biophysics at Keck School of Medicine of USC and a member of the diabetes and obesity research groups. Dr. Richey conducts research examining the relationship between diabetes, obesity and hypertension.

She has received research grants from the National Institute of Digestive, Diabetes and Kidney Disorders; National Institute of Heart, Lung and Blood; American Heart Association and the American Diabetes Association. Her research has resulted in publications in peer-reviewed medical journals. She is the immediate past president of the Los Leadership Council of the American Diabetes Association; chairperson of the Los Angeles African American Diabetes Task Force; and a peer grant reviewer for the Western and National Affiliates of the American Heart Association.

Research Funding

  • Summer Program in Diabetes and Obesity Research (SPIDOR)
    NIH · R25DK112738 · Aug 22, 2017 – Apr 30, 2022 · Role: Principal Investigator

Publications

  • Social network analysis of the CaRE2 health equity center: Team science in full display. Clin Transl Sci. 2024 03; 17(3):e13747.. View in PubMed
  • Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center: Structure, Innovations, and Initial Outcomes. Cancer Control. 2023 Jan-Dec; 30:10732748231197878.. View in PubMed
  • How do underserved adolescents want to learn about health? An exploration of health concerns, preferences, and resources utilized. J Natl Med Assoc. 2022 Oct; 114(5):518-524.. View in PubMed
  • An Analysis of U54 Partnerships to Advance Cancer Health Equity (PACHE) Publications. J Cancer Educ. 2022 06; 37(3):599-607.. View in PubMed
  • Assessing collaboration among team scientists within a triadic research center partnership. Qual Res Med Healthc. 2021 Oct 05; 5(2):9724.. View in PubMed
  • Interaction of Gut Microbiota and High-Sodium, Low-Potassium Diet in Altering Plasma Triglyceride Profiles Revealed by Lipidomics Analysis. Mol Nutr Food Res. 2019 12; 63(24):e1900752.. View in PubMed
  • Activation of NPRs and UCP1-independent pathway following CB1R antagonist treatment is associated with adipose tissue beiging in fat-fed male dogs. Am J Physiol Endocrinol Metab. 2019 09 01; 317(3):E535-E547.. View in PubMed
  • Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and Associated Diseases. Curr Diab Rep. 2017 09 14; 17(10):99.. View in PubMed
  • CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors. Am J Physiol Endocrinol Metab. 2015 Oct 15; 309(8):E747-58.. View in PubMed
  • Corrections: High-Fat Diet-Induced Insulin Resistance does not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets. PLoS One. 2015; 10(6):e0131033.. View in PubMed